{'fraction_non_alphanumeric': 0.023883696780893044, 'fraction_numerical': 0.003115264797507788, 'mean_word_length': 5.10126582278481, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Microarray-Based Cytogenetic Testing Illuminates Congenital Abnormalities and Cancer The Infinium CytoSNP-850 K BeadChip enables cytogenetics researchers to scan the entire genome for common or rare genomic alterations

Trilochan Sahoo, M.D. is an expert in the development, evaluation, and implementation of microarray-based cytogenomic technologies. A medical doctor by training, his interest in human genetics began early on in his career during his post-doctoral fellowship at Duke University. “My research was focused on identifying the cause of a group of Mendelian genetic disorders,” Dr. Sahoo said. “I moved to Baylor College of Medicine for a clinical cytogenetics fellowship, an area that was on the verge of becoming empowered by genomic analysis tools. I was very fortunate to work with some of the leaders of human genetics at Duke and Baylor. I have not regretted giving up clinical medicine to dive into molecular cytogenetics and human genetics.”